27.1 C
New York
Tuesday, July 22, 2025
Press ReleasesHealth CareHealth In Tech Announces Second Quarter 2025 Financial Results

Health In Tech Announces Second Quarter 2025 Financial Results

  • Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024.
  • Adjusted EBITDA of $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of $2.8 million, 1.2 times full year 2024.
  • Cash balance of $8.1 million.

STUART, Fla.  , July 21, 2025 /PRNewswire/ — Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the second quarter ended June 30, 2025.

Financial Highlights for the Second Quarter and First-Half of 2025: 

  • Revenues. Total revenues were $9.3 million, up 86% YoY. The first-half year revenues of $17.3 million, 89% of FY2024 total.
  • Billed Enrolled Employees. The number of billed enrolled employees (EEs) was 24,839, an increase of 5,738 EEs YoY.
  • Distribution. The number of Brokers, Third-party Administrator (“TPAs”) and Agencies expanded to 778 partners, up 87% YoY.
  • Pre-tax income. Pre-tax income was $0.8 million, more than doubled YoY; The first-half year pre-tax income of $1.5 million, 1.7x of FY2024.
  • Adjusted EBITDA. Adjusted EBITDA was $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of $2.8 million, 1.2x of FY2024.
  • Cash. Cash balance was $8.1 million as of June 30, 2025.
  • Accounts receivable, net. Accounts receivable balance was $1.3 million as of June 30, 2025, reduced $0.2 million YoY.

“We delivered another strong quarter of profitable growth, with total revenue reaching $9.3 million—up 86% year over year—and first-half revenues already at 89% of our full-year 2024 total,” said Tim Johnson, CEO of Health In Tech. “Our distribution network has expanded to 778 partners—an 87% increase year over year—reflecting our strategic focus on growing beyond traditional broker channels. We’ve established partnerships with TPAs offering technology-driven solutions, regional healthcare benefit providers, and service platforms that support small businesses. This approach is broadening our market reach and delivering greater value to our customers. The 30% increase in billed enrolled employees and strong adoption across our network underscore the demand for our differentiated services and offering.”

Mr. Johnson added, “What’s particularly exciting is that many of our partners are now using our platform to bundle healthcare insurance with their existing services, enabling them to serve small business employer better by offering integrated, end-to-end solutions. Our AI-powered platform is easy to implement and highly intuitive, making it an ideal tool for partners seeking efficiency and scalability. With a broader distribution footprint and multiple new relationships in place, we’re confident in our ability to maintain strong growth momentum through the rest of the year.”

“We’re pleased with our second quarter results, which reflect strong execution and disciplined financial management across the business,” said Julia Qian, CFO of Health In Tech. “Q2 revenue reached $9.3 million, bringing first-half revenue to $17.3 million—already 89% of our full-year 2024 total—driven by continued strategic expansion of our distribution network and strong customer acquisition. Adjusted EBITDA for the quarter was $1.6 million, up 134% year over year, with first-half adjusted EBITDA reaching $2.8 million—1.2 times our full-year 2024 result. First-half pretax income represented 8.8% of revenue, a nearly 300 basis point improvement year over year, demonstrating our ability to maintain expense discipline and allocate resources effectively to drive top-line growth. Supported by a solid $8.1 million cash position, we remain focused on investing in high-impact initiatives and advanced technology solutions that scale efficiently and sustain profitable growth.”.

Recent Business Developments and Highlights

  • Verdegard Administrators: an integrated, concierge-level TPA, owned by MedImpact, the largest independent pharmacy benefit manager (PBM) in the U.S., managing prescription benefits for over 20 million members and processing tens of billions in annual drug transactions. This partnership will enable us to reduce costs for small businesses.



  • Unified Health Plans: a premier TPA recognized for its extensive provider network across Kansas. It has extensive provider network and focuses on controlling cost drivers and improving care quality. Unified dominates several niche business sectors in Kansas. The partnership with HIT will bring healthcare insurance solutions to the business members.



  • HILB Group, one of Insurance Journal’s Top 25 ranked U.S. insurance brokers with over 2400 employee across more than 125+ branch locations in all 50 States. It partners with HIT to co-develop and distribute smarter, more transparent self-funded health benefit solutions to a much broader base of small and mid-size employers.



  • Baily Insurance, established in 1880, in its fourth -generation ownership. The agency has over 200 years of combined team experience. Licensed advisors partnering with multiple Carriers. Baily is a co-founder and key broker partner in Fusion Health Plans that provides better care services and tech-enabled solution. The collaboration with HIT will deliver faster underwriting, administration, and scalability.

Conference Call Details

Health In Tech will host a conference call to discuss the financial results for the second quarter of 2025 on July 21, 2025, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).

A live audio webcast will be available via the Investor Relations page of Health In Tech’s website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

Non-GAAP Financial Information

This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Use of ForwardLooking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and liquidity.

About Health In Tech 

Health In Tech (Nasdaq: “HIT”) is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

 

 

Health In Tech, Inc.

Consolidated Statements of Operations

(Unaudited)




Three Months Ended

June 30,

Six Months Ended

 June 30,




2025


2024


2025


2024


Revenues











Revenues from underwriting modeling (ICE)


$2,090,576


$1,639,105


$4,442,560


$3,423,740



Revenues from fees


7,223,273


3,363,385


12,886,273


6,703,681



    SMR


7,223,273


2,595,545


12,886,273


5,128,467



    HI Card



767,840



1,575,214



Total revenues


9,313,849


5,002,490


17,328,833


10,127,421



Cost of revenues


3,003,979


974,727


5,663,564


1,964,638



Gross profit


6,309,870


4,027,763


11,665,269


8,162,783



Operating expenses











Sales and marketing expenses


1,226,738


974,522


2,316,993


2,017,730



General and administrative expenses        


3,775,453


1,816,679


7,022,218


3,815,873



Research and development expenses


582,609


701,626


1,120,330


1,461,822



Total operating expenses


5,584,800


3,492,827


10,459,541


7,295,425



Other income (expense):











Interest income


108,198


31,339


193,564


55,651



Interest expenses



(165,000)



(330,000)



Other income




118,399




Total other income (expense), net


108,198


(133,661)


311,963


(274,349)



Income before income tax expense


$833,268


$401,275


$1,517,691


$593,009



Provision for income taxes


(202,637)


(63,268)


(388,468)


(154,466)



Net income


$630,631


$338,007


$1,129,223


$438,543



Net income per share











    Basic


$0.01


$0.01


$0.02


$0.01



    Diluted


$0.01


$0.01


$0.02


$0.01



Weighted average common stocks outstanding                                  











    Basic


55,382,395


51,769,358


55,003,233


51,769,358



    Diluted


55,632,357


51,769,358


57,004,070


51,769,358



 

 

Health In Tech, Inc.

Consolidated Balance Sheets

(Unaudited)




June 30, 2025


December 31, 2024


Assets 







Current assets







Cash


$8,138,166


$7,849,248



  Accounts receivable, net


1,281,131


1,647,103



  Other receivables


3,854,834


500,252



  Deferred offering costs


66,500




  Prepaid expenses and other current assets


1,513,017


787,161



Total current assets


14,853,648


10,783,764



Non-current assets







 Software


5,519,110


3,962,461



 Loans receivable, net


847,993


815,995



 Operating lease – right of use assets


173,896


206,269



  Long-term prepaid expenses


783,603




Total non-current assets


7,324,602


4,984,725



Total assets


$22,178,250


$15,768,489



Liabilities and stockholders’ equity







Current liabilities







Accounts payable and accrued expenses


$4,327,475


$1,858,840



Income taxes payable


34,944


205,253



Operating lease liabilities – current


71,418


66,881



   Other current liabilities


955,743




Total current liabilities


5,389,580


2,130,974



Non-current liabilities







Deferred tax liabilities


262,129


328,676



Operating lease liabilities – non-current


102,938


139,811



Total non-current liabilities


365,067


468,487



Total liabilities


5,754,647


2,599,461



Stockholders’ equity







Common stock, $0.001 par value; Class A Common stock 150,000,000 shares authorized, 44,679,664

  and 42,914,870 shares issued and outstanding as of June 30, 2025 and December 31, 2024,

  respectively


44,679


42,915



Common stock, $0.001 par value; Class B Common stock 50,000,000 shares authorized, 11,700,000

  shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively


11,700


11,700



Additional paid-in capital


11,296,605


9,173,017



Retained earnings


5,070,619


3,941,396



Total stockholders’ equity


16,423,603


13,169,028



Total liabilities and stockholders’ equity


$  22,178,250


$15,768,489



 

 

Health In Tech, Inc.

Consolidated Statements of Cash Flows

(Unaudited)




Three Months Ended

June 30,


Six Months Ended

June 30,




2025


2024


2025


2024


CASH FLOWS FROM OPERATING ACTIVITIES:











Net income


$630,631


$338,007


$1,129,223


$438,543



Adjustments to reconcile net income to net cash provided by operating activities:











     Write-off of accounts receivable


5,990



5,990




     Amortization expense


135,983


134,787


271,966


269,574



     Provision for refund liability


175,698



955,743




     Deferred tax expenses (benefits)


(32,074)


754


(66,547)


(59,316)



     Amortization of debt discount



165,000



330,000



    Interest income


(15,999)


(15,999)


(31,998)


(31,998)



    Stock-based compensation expense


707,963



1,201,134




    Changes in operating assets and liabilities:











             Accounts receivable, net


823,480


556,793


359,982


777,895



             Other receivables


134,954


382,279


(3,354,582)


619,372



             Prepaid expenses and other current assets


813,510


(1,737)


(204,241)


(91,725)



             Long-term prepaid expenses


(357,666)



(357,666)




             Operating lease right of use assets and liabilities, net


18


623


37


1,247



             Accounts payable and accrued expenses


(1,150,600)


(70,229)


2,269,897


(1,555,558)



             Income taxes payable


(390,612)


(223,737)


(170,309)


(111,705)



Net cash provided by operating activities


1,481,276


1,266,541


2,008,629


586,329



CASH FLOWS FROM INVESTING ACTIVITIES:











Development of software


(909,897)


(93,962)


(1,613,372)


(227,356)



Net cash used in investing activities


(909,897)


(93,962)


(1,613,372)


(227,356)



CASH FLOWS FROM FINANCING ACTIVITIES:











Payments of deferred offering costs


(8,250)


(368,910)


(106,339)


(612,120)



Net cash used in financing activities


(8,250)


(368,910)


(106,339)


(612,120)



Increase (decrease) in cash


563,129


803,669


288,918


(253,147)



Cash, beginning of the period


7,575,037


1,359,534


7,849,248


2,416,350



Cash, end of the period


8,138,166


2,163,203


8,138,166


2,163,203



Supplemental disclosures of cash flow information:











Cash paid for interest


$-


$-


$-


$-



Cash paid for income taxes


$625,323


$286,252


$625,323


$325,487



Summary of noncash investing and financing activities:











Accrued deferred offering costs included in accounts payable and accrued expenses


$-


$220,961


$-


$220,961



Accrued development of software included in accounts payable and accrued expenses


$265,243


$25,817


$265,243


$25,817



Issuance of Class A common stock for service 


$1,037,984


$-


$1,037,984


$-















 

Adjusted EBITDA Reconciliation

(Unaudited)




For Three Months Ended June 30,


For Six Months Ended June 30,



2024


2025


2024


2025

Net income


$ 338,007


$ 630,631


$438,543


$1,129,223

Interest (income) expenses


133,661


(108,198)


274,349


(193,564)

Depreciation and amortization


134,787


135,983


269,574


271,966

Income tax expense


63,268


202,637


154,466


388,468

Stock-based compensation expense



707,963



1,201,134

Total net adjustments


331,716


938,385


698,389


1,668,004

Adjusted EBITDA


$ 669,723


$1,569,016


$1,136,932


$2,797,227

 

Components of Operating Results

Revenues

While we generate our revenue primarily from small employers and insurance carriers, we grow our business primarily from offering solutions that streamline sales processes, enhance service delivery, and reduce the sales cycle duration for TPAs, MGUs, and Brokers. We offer our services through our three subsidiaries. Program services provided by SMR and MGU activities provided by ICE (including eDIYBS) are interdependent, as they cannot function effectively without being combined. Services provided by HI Card are an optional add-on to our other services, and cannot be offered on a standalone basis. Brokers that utilize the program services on behalf of the small employer provided by SMR and MGU activities provided by ICE, are not obligated to utilize our HI Card service. Currently ICE does not offer underwriting services as a standalone service. In the future, we may consider offering it as a standalone service.

Cost of revenues

Cost of revenues primarily consists of infrastructure costs to operate our platform such as hosting fees and fees paid to various third-party partners for access to their technology, services and amortization expenses of our capitalized internal-use software related to our platform. We mainly outsource captive management services and data services from the third-party companies. Our internal proprietary system seeks to consistently improve underwriting and services results through machine learning and data feeds. The captive management activities include introducing new carriers, conducting due diligence on carriers, conducting feasibility studies to determine the viability to be a stop-loss carrier on the platform, negotiating terms and contracts, coordinating audit requests, managing relationship with unrelated carriers and their regulators and auditor firms to ensure that our risk associated with our service offerings is minimized.

Sales and marketing expenses

Sales and marketing expenses primarily consist of personnel-related costs including salaries, stock-based compensation expense, benefits and commissions cost for our sales and marketing personnel. Sales and marketing expenses also include the costs for advertising, promotional and other marketing activities, as well as certain fees paid to various third-party for sales and customer acquisition.

General and administrative expenses

General and administrative expenses primarily consist of personnel-related costs and related expenses for our executives, finance, legal, human resources, technical support, and administrative personnel as well as the costs associated with professional fees for external legal, accounting and other consulting services, insurance premiums.

Research and development expenses

Research and development expenses primarily consist of personnel-related costs, including salaries, stock-based compensation expense and benefits for our research and development personnel. Additional expenses include costs related to the software development, quality assurance, and testing of new technology, and enhancement of our existing platform technology.

Adjusted EBITDA

Adjusted EBITDA represents our net income before net interest expense, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA, and we believe this approach provides a more meaningful measure by offering a clearer view of our underlying operational performance.

Financial Results Summary

(Unaudited

($ in millions)



Three Months Ended June 30,


Six Months Ended June 30,



2025



2024


% Change



2025



2024


% Change

Total revenues

$

9.3


$

5.0


86.2 %


$

17.3


$

10.1


71.1 %

GAAP gross margin


67.7 %



80.5 %


-12.8 %


$

67.3 %


$

80.6 %


-13.3 %

Income before income

   tax expense

$

0.8


$

0.4


107.7 %


$

1.5


$

0.6


155.9 %

Adjusted EBITDA

$

1.6


$

0.7


134.3 %


$

2.8


$

1.1


146.0 %

 

 

Investor Contact

Investor Relations:

ir@healthintech.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-second-quarter-2025-financial-results-302509811.html

SOURCE Health In Tech

Recent News